[ad_1] ZURICH (Reuters) – Influenza drug baloxavir marboxil significantly sped time to relief for patients highly vulnerable to serious complications, a late-stage clinical trial has shown, Swiss drugmaker Roche said on Thursday. …
Read More »Influenza drug accelerates symptom relief for at-risk patients: Roche
[ad_1] ZURICH (Reuters) – Baloxavir marboxil, an influenza drug, has significantly relieved patients who are extremely vulnerable to serious complications, a top-of-the-line clinical trial said Thursday, according to Swiss drug maker Roche. …
Read More »